• Conexeu opened a new R&D facility in Vancouver at adMare BioInnovations’ M4 Innovation Centre to expand its regenerative tissue development work.
• The site will anchor research, product development, commercialization for its CXU regenerative tissue platform, including the B.R.E.A.S.T. 3D-bioprinted breast matrix program.
• A ribbon-cutting ceremony was held June 23 to mark the launch of operations at the new laboratory.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conexeu Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606250830PRIMZONEFULLFEED9752465) on June 25, 2026, and is solely responsible for the information contained therein.